The low expression of MCT1 in colon cancer was beneficial for the development of cancer, and correlated with the deregulation of many butyrate-responsive genes that are involved in the processes of apoptosis, proliferation and differentiation in colon carcinoma tissue. The gene discussed is SLC16A1; the disease is colonic neoplasm.